NCT03143153 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 325
- group Id
- BG001
- value
- 321
- group Id
- BG002
- value
- 324
- group Id
- BG003
- value
- 970
- units
- Participants
- groups
- description
- Participants will receive treatment with nivolumab 3 mg/kg as a 30-minute infusion every 2 weeks and ipilimumab as a 30-minute infusion 1 mg/kg every 6 weeks.
- id
- BG000
- title
- Arm A: Nivolumab + Ipilimumab
- description
- Participants will receive treatment with nivolumab 240 mg as a 30-minute infusion on Day 1 and Day 15, fluorouracil 800 mg/m²/day as an IV continuous infusion on Day 1 through Day 5 (for 5 days), and cisplatin 80 mg/m² as a 30- to 120-minute infusion on Day 1 of 4-week cycle.
- id
- BG001
- title
- Arm B: Nivolumab + Chemotherapy
- description
- Participants will receive treatment with fluorouracil 800 mg/m²/day as an IV continuous infusion from Day 1 through Day 5 (for 5 days), and cisplatin 80 mg/m² as a 30- to 120-minute infusion on Day 1 of 4-week cycle.
- id
- BG002
- title
- Arm C: Chemotherapy
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.1
- value
- 62.2
- group Id
- BG001
- spread
- 9.2
- value
- 63.1
- group Id
- BG002
- spread
- 8.7
- value
- 63.3
- group Id
- BG003
- spread
- 9.0
- value
- 62.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 49
- group Id
- BG003
- value
- 173
- title
- Female
- measurements
- group Id
- BG000
- value
- 269
- group Id
- BG001
- value
- 253
- group Id
- BG002
- value
- 275
- group Id
- BG003
- value
- 797
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 85
- group Id
- BG002
- value
- 84
- group Id
- BG003
- value
- 248
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 11
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 4
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 8
- title
- Asian Indian
- categories
- measurements
- group Id
- BG000
- value
- 71
- group Id
- BG001
- value
- 74
- group Id
- BG002
- value
- 70
- group Id
- BG003
- value
- 215
- title
- Chinese
- categories
- measurements
- group Id
- BG000
- value
- 131
- group Id
- BG001
- value
- 126
- group Id
- BG002
- value
- 137
- group Id
- BG003
- value
- 394
- title
- Japanese
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 68
- title
- Asian Other
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 22
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 325
- group Id
- BG001
- value
- 321
- group Id
- BG002
- value
- 324
- group Id
- BG003
- value
- 970
- units
- Participants
- groups
- description
- Participants will receive treatment with nivolumab 3 mg/kg as a 30-minute infusion every 2 weeks and ipilimumab as a 30-minute infusion 1 mg/kg every 6 weeks.
- id
- BG000
- title
- Arm A: Nivolumab + Ipilimumab
- description
- Participants will receive treatment with nivolumab 240 mg as a 30-minute infusion on Day 1 and Day 15, fluorouracil 800 mg/m²/day as an IV continuous infusion on Day 1 through Day 5 (for 5 days), and cisplatin 80 mg/m² as a 30- to 120-minute infusion on Day 1 of 4-week cycle.
- id
- BG001
- title
- Arm B: Nivolumab + Chemotherapy
- description
- Participants will receive treatment with fluorouracil 800 mg/m²/day as an IV continuous infusion from Day 1 through Day 5 (for 5 days), and cisplatin 80 mg/m² as a 30- to 120-minute infusion on Day 1 of 4-week cycle.
- id
- BG002
- title
- Arm C: Chemotherapy
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.1
- value
- 62.2
- group Id
- BG001
- spread
- 9.2
- value
- 63.1
- group Id
- BG002
- spread
- 8.7
- value
- 63.3
- group Id
- BG003
- spread
- 9.0
- value
- 62.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 49
- group Id
- BG003
- value
- 173
- title
- Female
- measurements
- group Id
- BG000
- value
- 269
- group Id
- BG001
- value
- 253
- group Id
- BG002
- value
- 275
- group Id
- BG003
- value
- 797
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 85
- group Id
- BG002
- value
- 84
- group Id
- BG003
- value
- 248
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 11
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 4
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 8
- title
- Asian Indian
- categories
- measurements
- group Id
- BG000
- value
- 71
- group Id
- BG001
- value
- 74
- group Id
- BG002
- value
- 70
- group Id
- BG003
- value
- 215
- title
- Chinese
- categories
- measurements
- group Id
- BG000
- value
- 131
- group Id
- BG001
- value
- 126
- group Id
- BG002
- value
- 137
- group Id
- BG003
- value
- 394
- title
- Japanese
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 68
- title
- Asian Other
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 22
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle